C12N 2830/46
Elements influencing chromatin structure
Official title: elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
C12N2830/46 (Elements influencing chromatin structure) appears on 92 US grants and 159 published applications in this corpus.
Search patents in C12N- Granted patents
- 92
- Published applications
- 159
- Assignees
- 113
- Inventors
- 341
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 2 | 6 |
| 2003 | 1 | 12 |
| 2004 | 1 | 5 |
| 2005 | 6 | 9 |
| 2006 | 5 | 6 |
| 2007 | 5 | 6 |
| 2008 | 5 | 9 |
| 2009 | 4 | 5 |
| 2010 | 5 | 10 |
| 2011 | 2 | 4 |
| 2012 | 3 | 6 |
| 2013 | 1 | 5 |
| 2014 | 3 | 8 |
| 2015 | 9 | 6 |
| 2016 | 5 | 3 |
| 2017 | 2 | 8 |
| 2018 | 4 | 2 |
| 2019 | 6 | 4 |
| 2020 | 2 | 9 |
| 2021 | 3 | 10 |
| 2022 | 0 | 8 |
| 2023 | 7 | 4 |
| 2024 | 1 | 5 |
| 2025 | 7 | 1 |
| 2026 | 3 | 8 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Non-viral transgenesis15 Sep 2026US 12,735,719 B2The Regents of the University of California
- Chromatin-opening element for stable long term gene expression28 Apr 2026US 12,611,470 B2CZ Biohub SF, LLC
- Matrix attachment regions and uses in promoting gene expression3 Mar 2026US 12,565,663 B2Celltheon Corporation
- Compositions and methods related to kethoxal derivatives30 Sep 2025US 12,428,666 B2The University of Chicago
- Minimal promoter9 Sep 2025US 12,410,444 B2UCL Business PLC
- Respiratory vectors and uses thereof20 Aug 2026US 2026/0242803 A1Aldevron, LLC
- Double stranded dna compositions and related methods30 Jul 2026US 2026/0218169 A1Flagship Pioneering Innovations Vii, LLC
- Systems and methods for quantification and manipulation of genome geometry for cellular reprogramming and computation2 Jul 2026US 2026/0185109 A1Ann & Robert H. Lurie Children's Hospital of Chicago
- Dna compositions and related methods11 Jun 2026US 2026/0158053 A1Flagship Pioneering Innovations Vii, LLC
- Scaffold matrix attachment regions for gene therapy4 Jun 2026US 2026/0152759 A1Summation Bio, Inc.
Most cited
By later US patents
- Gene construct and its use43US 6,521,449 B1GSF-Forschungszentrum fur Umwelt und Gesundheit GmbH · 2003
- Gene expression system25US 7,371,542 B2Cytos Biotechnology AG · 2008
- Matrix attachment regions and methods for use thereof20US 7,129,062 B2Selexis S.A. · 2006
- Method for modulating gene expression by modifying the CpG content18US 8,859,275 B2Geneart AG · 2014
- Episomally replicating vector, its preparation and use17US 6,410,314 B1MultiGene Biotech GmbH Biozentrum am Hubland · 2002